NEW YORK, October 18, 2016 /PRNewswire/ --
In today's pre-market research, Stock-Callers.com takes note of the following Medical Laboratories and Research equities:
Thermo Fisher Scientific Inc. (NYSE: TMO), Bruker Corp. (NASDAQ: BRKR), VWR Corp. (NASDAQ: VWR), and Laboratory Corp. of America
Holdings (NYSE: LH). Pushing industry growth and company valuations are trends such as changing demographics, emerging economies,
advances in genetics, pathogen evolution, and climate change. These stocks research reports can be downloaded now by simply
registering for free at:
http://stock-callers.com/registration
Thermo Fisher Scientific
On Monday, shares in Massachusetts headquartered Thermo Fisher Scientific Inc. recorded a
trading volume of 1.61 million shares, which was above their three months average volume of 1.37 million shares. The stock ended
the day at $150.78, which was a slight correction of 0.61%. The Company's shares have gained 0.49%
in the last one month and 6.63% on an YTD basis. The stock is trading above its 200-day moving average by 3.49%. Furthermore,
shares of Thermo Fisher Scientific, which provides analytical instruments, equipment, reagents and consumables, software, and
services for research, manufacturing, analysis, discovery, and diagnostics worldwide, have a Relative Strength Index (RSI) of
39.03.
On September 22nd, 2016, research firm JP Morgan resumed its 'Overweight' rating on
the Company's stock, issuing a target price of $180 per share.
On October 17th, 2016, the company announced that it has joined the Cancer Moonshot,
an initiative led by Vice President Joe Biden aimed at making more therapies available to more
patients while also improving cancer detection at early stages and, ultimately, preventing the disease. Initially, Thermo Fisher will join a liquid biopsy-based precision oncology pilot, called the Blood Profiling Atlas
designed to make it easier for oncologists to access databases of liquid biopsy information when diagnosing patients. Your
complete research report on TMO can be retrieved for free at:
http://stock-callers.com/registration/?symbol=TMO
Bruker
Massachusetts headquartered Bruker Corp.'s stock finished yesterday's session 0.66% higher at
$21.28 and with a total trading volume of 417,701 shares. Shares of the Company, which together
with its subsidiaries, designs and manufactures scientific instruments, and analytical and diagnostic solutions worldwide, are
trading below their 50-day moving average by 3.93%. The stock has an RSI of 38.97.
On September 25th, 2016, Bruker announced that it has expanded its license agreement
with 3M for processing of FFPE tissue sections. Mass spectrometric imaging by MALDI-TOF is the leading mass spectrometric method
for the analysis of tissues, such as Formalin Fixed Paraffin Embedded (FFPE) tissues. Bruker and 3M have agreed to extend
Bruker´s global license for 3M´s patent from research to routine use. This is an important step towards developing future product
offerings for anatomical pathology laboratories, including clinically validated content libraries for specific clinical
indications. The license rights now cover the acquisition of MALDI spectra from FFPE sections for research and routine
applications. BRKR free report is just a click away at:
http://stock-callers.com/registration/?symbol=BRKR
VWR Corp.
At the closing bell on Monday, shares in Pennsylvania-based VWR Corp. rose 0.11%, ending the
day at $27.53. The stock recorded a trading volume of 439,494 shares. The Company's shares are
trading 0.73% above their 200-day moving average. Moreover, shares of VWR Corp., which together with its subsidiaries, operates
as an independent provider of laboratory products, services, and solutions to the life science, general research, and applied
markets, have an RSI of 39.48.
On October 7th, 2016, VWR announced that it will release its Q3 2016 financial
results on November 3rd, 2016, before the market opens. An investor conference call and
live webcast will be hosted by the company's management team that same day at 8:00 AM ET. Sign up
for your complimentary research report on VWR at:
http://stock-callers.com/registration/?symbol=VWR
Laboratory Corp. of America
Laboratory Corp. of America Holdings' stock ended the day 0.13% higher at $135.97 and with a
total trading volume of 298,746 shares. The Company's shares have gained 0.44% in the last month and 9.97% on an YTD basis. The
stock is trading 8.36% above its 200-day moving average. Additionally, shares of Laboratory Corp. of America (LabCorp), which
operates as an independent clinical laboratory company worldwide, have an RSI of 46.14.
On October 3rd, 2016, the company announced that its Zero Coupon Convertible
Subordinated Notes due 2021 are convertible into cash and LabCorp's Common Stock, if any, subject to the terms of the Zero Coupon
Notes and the Indenture, dated as of October 24th, 2006, between LabCorp and The Bank of
New York Mellon, as trustee and the conversion agent. In order to exercise the option to convert all or a portion of the Zero
Coupon Notes, holders must validly surrender their Zero Coupon Notes at any time during the calendar quarter through the close of
business at 5:00 p.m., ET, on December 30th, 2016.
Register for free on Stock-Callers.com and download the latest research report on LH at:
http://stock-callers.com/registration/?symbol=LH
--
Stock Callers:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment
newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments.
One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports
covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered
analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and
micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a
third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on
analyst credentials, please email info@stock-callers.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is
believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed
any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently
reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or
interfere in the application of such procedures by the third-party research service company to the articles, documents or
reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or
the Reviewer in any way.
NO WARRANTY
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this
document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss
arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document.
Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing
of the information, or (2) warrant any results from use of the information. The included information is subject to change without
notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities
mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers
in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with
any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
http://stock-callers.com/legal-disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a
company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@stock-callers.com
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA